gestational diabetes and driving

Last edited 06/2019 and last reviewed 01/2021

With respect to Group 1 entitlement to drive:

If temporary insulin treatment e.g. gestational diabetes, post-myocardial infarction, participants in oral/inhaled insulin trials.

    • provided they are under medical supervision and have not been advised by their doctor that they are at risk of disabling hypoglycaemia, need not notify DVLA. If experiencing disabling hypoglycaemia, DVLA should be notified
    • notify DVLA if treatment continues for more than 3 months or for more than 3 months after delivery for gestational diabetes

Otherwise guidance is as for diabetes and driving (linked item).

For up to date guidance then consult the DVLA website.

Reference: